Literature DB >> 26576267

Microbiome in NAFLD and ALD.

Irina A Kirpich1, Dipendra Parajuli2, Craig J McClain3.   

Abstract

Entities:  

Year:  2015        PMID: 26576267      PMCID: PMC4643302          DOI: 10.1002/cld.494

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN: 2046-2484


× No keyword cloud information.
  15 in total

1.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

Authors:  Lixin Zhu; Susan S Baker; Chelsea Gill; Wensheng Liu; Razan Alkhouri; Robert D Baker; Steven R Gill
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

4.  Microbial ecology: human gut microbes associated with obesity.

Authors:  Ruth E Ley; Peter J Turnbaugh; Samuel Klein; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

6.  Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice.

Authors:  Xue Shi; Xiaoli Wei; Xinmin Yin; Yuhua Wang; Min Zhang; Cuiqing Zhao; Haiyang Zhao; Craig J McClain; Wenke Feng; Xiang Zhang
Journal:  J Proteome Res       Date:  2015-01-27       Impact factor: 4.466

7.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

Authors:  Irina A Kirpich; Natalia V Solovieva; Svetlana N Leikhter; Natalia A Shidakova; Oxsana V Lebedeva; Pavel I Sidorov; Tatjana A Bazhukova; Andrej G Soloviev; Shirish S Barve; Craig J McClain; Matt Cave
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

8.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 9.  The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.

Authors:  Silvia M Ferolla; Geyza N A Armiliato; Cláudia A Couto; Teresa C A Ferrari
Journal:  Nutrients       Date:  2014-12-03       Impact factor: 5.717

10.  Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment.

Authors:  Lara Bull-Otterson; Wenke Feng; Irina Kirpich; Yuhua Wang; Xiang Qin; Yanlong Liu; Leila Gobejishvili; Swati Joshi-Barve; Tulin Ayvaz; Joseph Petrosino; Maiying Kong; David Barker; Craig McClain; Shirish Barve
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

View more
  4 in total

Review 1.  Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease.

Authors:  Emma T Saltzman; Talia Palacios; Michael Thomsen; Luis Vitetta
Journal:  Front Microbiol       Date:  2018-01-30       Impact factor: 5.640

Review 2.  Sulforaphane: Its "Coming of Age" as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease.

Authors:  Christine A Houghton
Journal:  Oxid Med Cell Longev       Date:  2019-10-14       Impact factor: 6.543

3.  Comparing the protective effects of resveratrol, curcumin and sulforaphane against LPS/IFN-γ-mediated inflammation in doxorubicin-treated macrophages.

Authors:  Haidy A Saleh; Eman Ramdan; Mohey M Elmazar; Hassan M E Azzazy; Anwar Abdelnaser
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Probiotic Lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration.

Authors:  Juseok Kim; Seong Woo Ahn; Joon Yong Kim; Tae Woong Whon; Seul Ki Lim; Byung Hee Ryu; Nam Soo Han; Hak-Jong Choi; Seong Woon Roh; Se Hee Lee
Journal:  Front Microbiol       Date:  2022-08-18       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.